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Abstract 
Objectives: This study examined the relation of dietary fat intake and blood lipid levels 
in a young African American and white population with subclinical MRI measures taken 
at a later age.   
Methods: Dietary intake was assessed 3 times over 20 years and fasting blood lipids 
measured x times over 25 years among CARDIA participants who were 18-30 years old 
at baseline (n=5111). Brain MRI measures were taken at year 25 in a sub-sample 
(n=690).  Spearman partial correlations were used to evaluate relations of dietary intake 
and blood lipid levels with MRI measurements; analyses were stratified by gender and 
adjusted for age, race, education, smoking, energy and alcohol intakes, BMI, and 
intracranial volume.  
Results: Intakes of energy, alcohol and % kcal from total fat and saturated fat were 
greater in men than women.  Total fat intake was not related to any brain MRI measures.  
However, both grams and % kcal from saturated fat were inversely related to white 
matter fractional anisotropy (FA) in men only (r = -0.12; p=0.03 and r=-0.14; p=0.01, 
respectively).  Further, grams and % kcal from saturated fat were positively related to 
abnormal white matter tissue volume in women only (r=0.13; p=0.01 and r= 0.13; 
p=0.02, respectively). Omega3 fatty acids were inversely correlated to abnormal white 
matter (men: r=-0.11; p=0.05, women: r=-0.14; p=0.01).  Additionally, omega3 fatty 
acids were inversely correlated with total ventricle volume in men (r=-0.11; p=0.05), but 
not in women.  
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     In men there were significant inverse correlations between total cholesterol and total 
brain volume (r=0.12, p=0.03) . Furthermore, there were significant positive correlations 
between both total (r=0.11, p=0.05) and LDL-cholesterol (r=0.12, p=0.04) and total 
ventricle volume in men. In women there was a significant inverse correlation between 
triglycerides and total brain volume (r=-0.12, p=0.03) and normal gray matter (r=-0.15, 
p<0.01). In addition, there was also a significant inverse relationship between total 
cholesterol and total brain volume (r=-0.11, p=0.05) in women. 
Conclusions: Given these study findings, we conclude that omega3 fatty acid intake and 
saturated fat may be associated with brain MRI measures in a beneficial and detrimental 
manner, respectively.  Our studies further reveal interesting inverse relations between 
total and normal gray brain volumes with blood lipids in men and women. Additionally 
total ventricle volume was positively associated with blood lipids in men. Further 
research is needed to elucidate the relations of dietary fat intake and blood lipids with 
brain MRI measures
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A. Introduction 
A.1  Specific Aims 
 It has been shown that dietary intake of fatty acids as well as blood lipids may alter 
brain status in both positive and negative ways depending on the exposure of interest. 
Omega 3 fatty acids and elevated HDL-cholesterol levels are correlated with improved 
cognitive function and a decreased risk for stroke whereas other studies show that 
saturated fatty acid intake, elevated plasma LDL-cholesterol, and triglycerides are 
positively associated with decreased cognitive function and an increased risk for stroke. 
There is a critical need to determine the extent of the relationships of dietary fat intake 
and blood lipids with markers of brain function with regard to brain function and stroke.  
 The objective of this study is to determine the relationships of dietary fat intake and 
plasma lipids--traditional risk factors for vascular disease—with brain function 
parameters: brain volume and fractional anisotropy (FA). Magnetic resonance imaging 
(MRI) measures which express these variables within specific regions of the brain as well 
as the whole brain are available in 791 participants at one exam in the Coronary Artery 
Risk Development in Young Adults (CARDIA) study, a multi-center population-based 
prospective study of CVD risk factor evolution in black and white men and women. 
Brain volume is known to elucidate the degree of appropriate brain function and activity. 
The FA measurements reveal the organization of axon tracts.  Our central hypothesis is 
that high saturated fatty acid intake, total cholesterol, blood LDL-c, and triglycerides will 
predict the brain parameters associated with reduced brain function and brain markers of 
stroke, while omega-3 fatty acids and HDL-c will be inversely related. The rationale is 
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that traditional risk factors for CVD observed at an early age will be associated with MRI 
measures indicative of stroke and cognitive function at a later age. Our specific aims are 
to: 
1)   Determine the associations of dietary intake of saturated and omega 3 fatty 
acids with MRI measures in the brain which indicate function and markers 
of stroke.  
 
2)   Determine the relationship between blood lipids and MRI measures in the 
brain which indicate function and markers of stroke.  
 
     Our expectation is that our study will fill the large knowledge gap between traditional 
risk factors for CVD and the resulting state within the brain as characterized by MRI 
parameters. Our study population is unique given the young age and two race groups 
including white and African American men and women. Never before have these 
parameters of brain function and structure been examined relative to CVD risk factors in 
a younger population. The significance of this project is that identifying, early on, 
lifestyle and clinical factors associated with these brain markers of function and stroke 
will allow for the development of appropriate intervention strategies to prevent or slow 
down the progression of cognitive decline and the development of stroke. Our research 
will form the basis for future intervention studies to confirm the importance of optimal 
CVD risk factors for brain health and the prevention of stroke.  
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A.2 Background 
 
     Stroke is the third or fourth leading cause of death in the United States and causes 
more long-term disabilities than any other disease (Towfighi and Saver 2011, 2351-
2355). Stroke is caused by a compromise of blood flow to the brain by either a blockage 
of blood vessels supply the brain (ischemic stroke) or blood vessel rupture (hemorrhagic 
stroke)  (Raji et al. 2010a, 353-364). There are well-established relationships between 
MRI measures in the brain and the presence of stroke and cognitive dysfunction in human 
populations. Similarly risk factors for CVD including dietary intake of fatty acids, and 
blood lipids are also risk factors for stroke and cognitive dysfunction. What remains 
unknown, however, are the relationships between these CVD risk factors and the relevant 
MRI measures in the brain which likely account for subsequent ischemia, hemorrhage, 
and cognitive dysfunction. Thus, to prevent adverse alterations in the brain, it is of great 
importance, as a first step, to identify in a young population risk factors that are related to 
these measures in the brain which are characteristic in populations at risk for stroke and 
cognitive decline. The following MRI measures in the brain are associated with stroke 
and cognitive decline: 
 
A.3 Normal/Abnormal Tissue Volume and Fractional Anisotropy (FA) 
     Reduced brain volume in non-ventricular brain tissue matter and increased axonal 
discontinuity, as assessed with FA measurements, are characteristic of cognitive decline 
(Tiberio et al. 2005, 1001-1007). FA measurements reflect the alignment and structural 
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integrity of fiber tracts in the brain (Basser 1995, 333-344). Thus a lower FA numeric 
value reflects an increased severity of tissue damage and disorganization of axonal 
projections  (Inglese et al. 2005, 298-303; Huisman et al. 2004, 370-376). Similarly 
following a stroke, there is a reduction in FA due to the cellular damage from ischemia 
(Werring et al. 2000, 269-272). There are no published studies, that we are aware, which 
report the relation between CVD risk factors and FA in any human populations. Our 
study will assess these relationships. 
     The relative mass of abnormal volume of regions of interest reflects the presence of 
ischemic tissue or an area associated with brain atrophy, reduced CBF, gait disorders, and 
cognitive impairment (DeCarli et al. 1995a, 2077-2084). Increased abnormal white 
matter intensity is associated with the risk for stroke, concurrent silent stroke, and 
cognitive decline in populations of healthy adults (DeCarli et al. 1995b, 2077-2084; 
Longstreth et al. 1996, 1274-1282). Reduced brain volume in the gray and white matter is 
associated with various brain diseases such as schizophrenia, attention-deficit-disorders, 
and autism (Tiberio et al. 2005, 1001-1007). Whereas increased ventricle volume is 
associated with cognitive decline and dementia (Haxby et al. 1992, 2029-2029) and with 
other cardiovascular risk factors including diabetes in the ARIC study cohort (Knopman 
et al. 2005, 876-881). Blood LDL-c is a risk factor for impairment related to brain 
volume analyses at single time points in elderly populations (Raji et al. 2010b, 353-364). 
However, our study will assess these relationships in a young population where 
longitudinal analysis may be applied.  
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A.4 Dietary Fatty Acid Intake and Brain Measures 
 
     It is known that fatty acid intake has marked roles with regard to brain function. 
Saturated fat intake has a pronounced negative impact on the function of the brain in 
addition to its well-known role in the promotion of heart disease. Saturated fat intake has 
been shown to increase risk for dementia whereas omega-3 fatty acids have a protective 
effect on cognitive function in the elderly (Del Parigi et al. 2006, 1-19). Additionally a 
diet high in saturated fat is associated with increased rates of cognitive decline over 6 
years in a biracial community population (Morris et al. 2004, 1573-1579). Thus it is 
likely that decreases in brain volume and axonal density may be present within the brain 
as a result of a high intake of saturated-fatty acids. Evidence suggests that dietary intake 
of saturated fatty acids results in alterations in plasma phospholipid composition and 
subsequent stroke risk. In humans, plasma phospholipid saturated fatty acids are 
associated with an increased risk for stroke (Wiberg et al. 2006, 2898-2903). However a 
meta-analysis in 8 studies reveals that the dynamics of this relationship are unclear 
(Scarborough et al. 2010, 458).  
     Omega-3 fatty acids are known to be required for the development and function of 
both the brain and the retina (Neuringer, Anderson, and Connor 1988, 517-541). Omega-
3 fatty acids compose the membranes of brain cells as well as participate in the regulation 
of blood flow within the cerebrum (Bourre 2004). Omega-3 fatty acids are also necessary 
for synapse development and thus affect the density of axonal projections (McGahon et 
al. 1999, 305-314). Omega-3 fatty acid supplementation has been associated with a 
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reversal of cerebral atrophy in schizophrenia and Huntington’s Disease and a reduction in 
ventricular volume in treatment-resistant depression (Puri et al. 2001, 560; Puri et al. 
2000, 57; Puri et al. 2002, 123; Logan 2003, 410-425). Omega-3 fatty acid 
supplementation results in neuroprotection from ischemic events in neonates and likely 
occurs through its anti-inflammatory action (Zhang et al. 2010, 2341-2347). Similarly an 
increased intake of omega-3 fatty acid-containing fish is associated with a decreased risk 
for ischemic stroke in men and women (Larsson and Orsini 2011; Larsson, Virtamo, and 
Wolk 2011, 487-493). 
     We will examine the relations of both dietary intake of saturated and omega3 fatty 
acids with brain normal and abnormal volume, and fractional anisotropy.  
 
A.5 Blood Lipids and Brain Measures  
 
     Little research has been done to determine the associations between blood cholesterol 
and triglycerides with MRI measures of brain function and stroke. In particular we are 
interested in the association between blood total cholesterol, low-density lipoprotein 
(LDL), high-density lipoprotein (HDL), and triglyceride levels and MRI measures in the 
brain taken subsequently. In one study high levels of LDL-cholesterol were associated 
with a low gray matter volume (Whalley et al. 2003, 173-176). Blood LDL-cholesterol is 
also associated with an increasing number of lesions in the brains of patients with 
multiple sclerosis (Giubilei et al. 2002, 109-112). Similarly blood levels of oxidized 
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LDL-cholesterol are associated with ischemic lesion detected by diffusion weighted MRI 
imaging and predicts the size of brain infarctions (Uno et al. 2005, 94-102).  
     With regard to cognitive function, elevated blood LDL and decreased blood HDL-
cholesterol are risk factors for vascular dementia (Reitz et al. 2004, 705). High total 
cholesterol levels are associated with memory dysfunction and cognitive decline 
(Desmond et al. 1993, 162), (Yaffe et al. 2002, 378). We predict that blood LDL-
cholesterol and triglyceride levels will be positively associated with reduced brain 
volume and axonal organization assessed with FA measurements. Blood HDL-cholesterol 
is positively associated with cognitive performance in a population of centenarians and is 
expected to be positively associated with measures of cognitive performance (Atzmon et 
al. 2002, M712). We will examine the relation of blood lipids with normal/abnormal 
brain volume and fractional anisotropy. 
     Through our available data set we have access to dietary intake and blood lipid 
variables as well as the described recently acquired MRI parameters. We will be able to 
determine correlations between prior dietary fatty acid intake and blood lipids and the 
following MRI parameters. Determination of these associations will prove very useful in 
preventative measures with regard to stroke and brain function. We expect to establish 
important relationships that will affect the health of millions nationwide.  
 
A.6 Definitions 
 
Adverse/Negative brain function (with regard to cognitive function and stroke) is 
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characterized by: 
- decreased gray matter volume: marker of cognitive function 
- increased white matter volume: marker of cognitive function and stroke 
- increased ventricular volume: marker of cognitive function 
- decreased FA: marker of cognitive function and stroke 
 
A.7 Hypothesis 
 
     We hypothesize that dietary intake of saturated fatty acids will be negatively related to 
brain function while omega 3 fatty acids will be positively related to function. We 
hypothesize that total cholesterol, LDL-c and triglycerides will be negatively related to 
brain function whereas HDL-c will be positively related to brain function in a young to 
middle-aged adult population. 
 
A.8 Hypothetical Mechanisms  
 
      Our hypothesis that dietary intake of saturated fatty acids will be negatively 
associated with brain function may occur through several potential mechanisms. One 
mechanism involves changes in the composition of phospholipids in the plasma 
membrane. Dietary intake of saturated fat is associated with alteration in 
phophatidylcholine profile in neuronal membranes indicating that membrane 
permeability and integrity may be affected (Greenwood and Winocur 1996, 451). 
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Activation of astroglial cells by physiological processes results in subsequent fluctuations 
in brain tissue oxygenation and potentially cognitive function. Specifically, cross-talk 
between neurons and glial cells resulting in an influx of calcium into glial cells accounts 
for fluctuations in BOLD signal detected by fMRI (DiNuzzo et al. 2011, 3010-3018; 
Brenneman and Rutledge 1979, 295-304). Additionally saturated fatty acids result in an 
alteration of dopamine and norepinephrine transport in the cerebral cortex of rats via 
changes in membrane fluidity (Brenneman and Rutledge 1979, 295-304).  
     A potential mechanism to account for the effect of saturated fat intake and elevated 
blood lipids on brain function involves the upregulation of inflammatory processes. High 
fat diets are shown to increase the formation of reactive oxygen species and NADPH 
oxidate-mediated oxidative stress (Zhang et al. 2005, 318-325). High-fat diets also 
increase inflammatory prostaglandin 2, COS-2, and NKFB translocation in the cerebral 
cortex of rats (Zhang et al. 2005, 318-325). Physiological processes that affect cortical 
dynamics via astrocytes in mammals may involve metabolic responses to dietary 
challenges such as dietary saturated fatty acids intake or metabolic imbalance due to 
elevated blood LDL-c and triglycerides (Cunningham et al. 2006, 5597-5601). 
Additionally direct effects of these stressors on inflammatory processes could result in 
calcium influx and subsequent activation of glial cells resulting in deterioration of brain 
processes. Blood flow acts directly on astrocytes in the brain and vasoactive compounds 
present in the blood have marked changes on astrocyte and subsequent brain activity 
(Rossi 2006, 159-161).  
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 Omega-3 fatty acids affect brain function through several mechanisms involving 
effects on neurons signaling and physical processes such as membrane fluidity and 
bilayer thickness (Horrocks and Farooqui 2004, 361-372). The importance of these 
mechanisms is supported by the fact that deficiencies of docosahexanoic acid are 
associated with decreased neuron signaling, gene expression, and inflammation 
(Horrocks and Farooqui 2004, 361-372). Thus it may be reasonably proposed that omega-
3 fatty acid intakes result in decreased inflammation and improved brain function and 
integrity through, for example, the expression of appropriate genes required for neuronal 
survival and growth.  
 
A.9 Research Design and Methods 
 
Overview   
 
     We have available through the Coronary Artery Risk Development in Young Adults 
(CARDIA) data from participants of this observational study about the etiology of 
cardiovascular disease. At year 0, 2, 5, 7, 10, 15, and 20, dietary intake measurements of 
fatty acids intake an/ord blood lipids were obtained from the participants. At year 25 a 
brain MRI analysis was performed on these participants. The MRI variables for which we 
have data include brain volume and FA. Data for these variables is reported as individual 
data values within voxels or within particular regions of the brain (RIO: Regions of 
Interest) as well as for the whole brain. Our main approach in our studies is to assess how 
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prior dietary intake of nutrients such as fatty acids and blood lipids predicts these MRI 
parameters at year 25.  
Study Participants 
     The data for our proposed study comes from the Coronary Artery Risk Development 
in Young Adults (CARDIA) cohort of white and black men and women in the United 
States. Data are acquired from 791 participants between the ages of 18 and 30 years old 
at baseline (1985-1986). Exclusion criteria include unusually high (> 8000 kcal for men 
and >6000 kcal for women) or low (<800 for men and <600 for women) caloric intake at 
year 0 or 7, the presence of pregnancy or lactation in women at year 0 or 7, participants 
who had elevated blood pressure or diabetes at baseline, and participants with non-fasting 
blood samples. Blood pressure measurements taken during pregnancy were treated as 
missing. Additional exclusion criteria were implemented for MRI scan participants. 
Participation for MRI scanning was reduced due to disinterest, absence, claustrophobia, 
ineligibility, scheduling conflict, MRI contraindication, clinical MRI alert levels of 3 or 
4, or scanning technical difficulties. Following the implementation of exclusion criteria, 
the total sample in these analyses was n=724; including black men (n = 137), black 
women (n = 160), white men (n = 207), and white women (n = 220). All participants 
gave written consent, and the institutional review boards of the participating field centers 
gave approval for the study.    
 
Data Acquisition 
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     For the brain MRI study, the coordinating and clinical centers are located in 
Birmingham, AL, Minneapolis, MN, and Oakland, CA. The participants have been 
followed up for assessment of clinical factors at years 0, 2, 5, 7, 10, 15, 20, and 25 years 
from baseline. Magnetic Resonance Imaging (MRI) data at year 25 were acquired from 
these participants.  
 
Clinical Assessment of Blood Lipid Parameters 
 
     For analysis of blood lipid parameters, subjects fasted for >8 hrs and were asked to 
avoid smoking and physical activity for two hours prior to the CARDIA exam. Blood 
samples were collected and stored in vials at -70 degrees C. The clinical parameter of 
importance for our proposed study is the plasma levels of triglycerides, a risk factor for 
coronary heart disease (Wilson et al. 1998, 1837-1847). 
 
CARDIA Diet History Assessment 
 
     Dietary intake at years 0, 7, and 20 was determined based on interviewer-administered 
food intake questionnaires. The standard CARDIA diet questionnaire queried food intake, 
frequency of consumption and portion size. Condiments and type of fat used in 
preparation or added at the table were also queried. This was important for our 
assessment of dietary fatty acid intake. Daily nutrient intake was calculated using nutrient 
data from the National Nutrient Database for Standard Reference (NNDS) which 
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incorporated the macronutrient and micronutrient content of 18,000 foods and 7,000 
brand products. This database is known for its comprehensiveness with regard to the vast 
number of food variations and the components of measurements.  
 The reliability and comparative validity of the CARDIA dietary history 
questionnaire was assessed in participants. Seven telephone-assessed 24-hour dietary 
intake recalls were administered and compared with the standard CARDIA estimation of 
daily dietary intake (Liu et al. 1994, 15). No significant differences were observed 
between reported nutrient intakes assessed by both these methods in white participants. In 
black participants there was less consistency. Overall this study verified the reasonability 
of this CARDIA dietary questionnaire in accurately predicting nutrient intake. The 
dietary parameters which are of interest to our proposed study include the following: 
     Omega-3 and saturated fatty acid intake. Based on reported intake of various food 
types, we are able to calculate the intake of both omega-3 fatty acids and saturated fatty 
acids.  
Magnetic Resonance Imaging Data 
     At year 25, participants underwent an MRI analysis. An initial testing scan was 
performed for review and approval by the University of Pennsylvania Medical Center. 
Study scans were performed at the three field centers and acquired data was sent to the 
MRI reading centers in the University of Pennsylvania where a DICOM image transfer 
system was used for analysis of data. All field center personnel involved were 
appropriately trained for MRI scan acquisition. All participants were required to sign 
consent forms and were educated on the scanning procedures prior to the hour-long 
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session. Field centers were required to rigorously follow scanning protocol and maintain 
participant comfort throughout the scanning procedures.   
 
     Scanning pulse sequences were performed in the order of first to last in the following 
list: 3 plane Gradient echo localizer for positioning, Sagittal 3D T1‐weighted sequence 
for entire brain coverage, Sagittal 3D FLAIR images from matching slice positions in 
Series 2, Sagittal 3D T2‐weighted images matching slice positions in Series 2, Axial ASL 
(Arterial Spin Labeling) perfusion sequence, Axial ASL (Arterial Spin Labeling) 
calibration sequence, Axial DTI (Diffusion Tensor Imaging) sequence, Axial BOLD 
(Blood Oxygen Level Dependent) FMRI sequence (resting state), Axial BOLD (Blood 
Oxygen Level Dependent) FMRI sequence (16 second breath‐hold).Results were sent to 
the coordinating center for data storage and transfer to coordinating universities 
(University of Minnesota in our case).  
 
      The DICOM analysis calculated various parameters within brain regions (voxel-
derived) and in larger portions of the brain including the whole brain. The database of 
MRI data includes values for many brain regions of interest including the whole brain, 
gray matter, white matter, ventricles, cerebellum, the major gyri, and many other smaller 
areas. The following parameters are included in our analysis: 
 
Brain Volume: Brain volume calculations measure the volume in cubic centimeters 
(cm3) within each region of interest. Brain volumes are categorized as either normal or 
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abnormal volume. We are interested in the volumes of our chosen regions of interest with 
respect to our exposures.  
 
FA: The mean FA numeric measurements are acquired through diffusion tensor MRI 
Thus we are able to characterize the specific organization of neuronal circuits as related 
to our exposures. 
 
Regions of Interest  
 
     We will assess each of the described MRI parameters in the following regions of 
interest: 
 
Whole brain: Analysis of the whole brain will give rise to nonspecific general measures 
of cognitive function. This region of interest is of particular interest with regard to 
volume, CBF, anisotropy, and the diffusion coefficient. Whole brain measurements have 
been used for analysis and prognosis of a variety of cognitive diseases (Abell et al. 1999, 
1647; Alavi et al. 1993, 1681). 
 
Gray Matter: Gray matter consists of the major central nervous system components: the 
neuron cell bodies along with attached dendrites and axons, the capillaries, and the glial 
cells which play a supportive role to the surrounding neurons. Decreased gray matter 
volume or MRI hypointensity are associated with cognitive impairment (Brass et al. 
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2006, 437-444). Reduced gray matter volume and damage to this area is characteristic of 
neurological diseases such as multiple sclerosis (Geurts and Barkhof 2008, 841-851).  
 
White Matter: White matter is composed of glial cells and myelin sheaths that cover 
tracts of axons. Lesions in the white matter are associated with cognitive dysfunction due 
to the role of white matter in conveying signal between difference regions in the brain (de 
Groot et al. 2000, 145-151). 
 
Ventricle: The ventricles are large spaces present in the brain which contain circulating 
cerebrospinal fluid. The ventricular system is composed of the third ventricle, the right 
and left lateral ventricles, and fourth ventricle. The total volume of the ventricles is 
detected by the MRI measures and will be used for our analysis. Increased ventricular 
volume accompanies reduced brain volume and aging indicating reduced function and 
cognitive performance (Scahill et al. 2003, 989; DeCarli et al. 1995c, 2077-2084; 
Johnstone et al. 1976, 924-926). 
 
Statistical Analysis  
 
     The program PC-SAS software (version 8; SAS Institute, Cary, NC) was used for all 
data analyses. For all exposures, variables were treated as continuous variables averaged 
over 20 years (years 0, 2, 5, 7, 15, or 20). Distributions were examined for normality and 
skewed distributions normalized where appropriate.  Descriptive statistics for continuous 
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variables were presented as means (SD) or (SE) when adjusted for confounding factors 
and frequencies (%) for categorical variables by sex group.  Spearman correlations 
evaluated the relations of dietary fatty acid intake and plasma lipids with brain MRI 
measures by gender.  These models were adjusted for several confounding factors, 
including age, race, field center, education, smoking, family history of heart 
disease/stroke, BMI, OC use, and other potential confounding factors.    
 The employed statistical models incorporated several potential confounding 
factors. Family history of heart disease and stroke is available through the CARDIA data 
set and considered as a potential confounder in the analysis. This adjustment accounted 
for some genetic variables and hereditary propensities for these diseases and the 
associated disease risk (Neufeld and Goldbourt 1983, 943-954; Alberts 1991, 276-280). 
Age was adjusted for in the models to remove any age related progression of MRI 
components (Raz et al. 2005, 1676-1689). Data were stratified by gender to compensate, 
for example, for neuroprotective effects of estrogen and progesterone (ROOF and HALL 
2000, 367-388). Physical activity was also adjusted for to account for proposed benefits 
on cognitive function (56). Additionally, we also accounted for race, field center, and 
socioeconomical status.  
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B. The Relation between Dietary Intake of Fat and Brain MRI Measures 
 
B.1 Introduction  
 
     Epidemiologic studies have shown that dietary intake influences cognitive function 
and risk of stroke assessed with brain MRI measures such as brain volume and fractional 
anisotropy (Tangney et al. 2011, 1276-1282; Gardener et al. 2012, 251). Although few 
studies have examined the relations of dietary fat intake and subclinical measures of brain 
function, several studies have shown inverse relations of dietary fat intake with cognitive 
function and stroke. Cross-sectional studies in middle-aged adults have shown that high 
total fat and saturated fat intakes were associated with greater risk for cognitive 
impairment assessed by an extensive battery of cognitive tests which measured memory 
and motor function (Kalmijn et al. 2004, 275-280; Ortega et al. 1997, 803-809). 
Prospective studies in elderly adults have shown positive associations between dietary 
saturated fat and risk for cognitive decline (Morris et al. 2004, 1573-1579).  Conversely, 
saturated fat intake has been inconsistently related to the development of stroke (Micha 
and Mozaffarian 2010, 893-905).  A meta-analysis of 21 prospective studies with 5-23 
years of follow up found that saturated fat consumption assessed by dietary recalls or 
food frequency questionnaires was not related to risk of stroke (0.81, 95 % CI: 0.62-1.05) 
(Siri-Tarino et al. 2010, 535-546; Corvol et al. 2003, 669). The inconsistent results of the 
relations between saturated fat and cognitive function and stroke may be due to interplay 
of oxidative stress and neurochemicals involved in the energy homeostasis of brain cells 
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(Wu, Ying, and Gomez‐Pinilla 2004, 1699-1707)  In addition, the differences in 
measurement or assessment of stroke and cognitive function in these studies, such as the 
extensive battery of motor, memory, attention, and other behavioral measurements for 
cognitive function or the assessment of stroke, such as using the number of strokes or size 
of ischemic lesions as the outcome, may also account for the differential study findings 
((DeCarli et al. 1995b, 2077-2084; Bowman et al. 2012, 241-249).   
     Omega3 fatty acid intake has been positively related to both cognitive function and 
inversely with stroke outcome in animal studies as well as in cross-sectional studies 
among elderly adults (Zhang et al. 2005, 318-325; Kalmijn et al. 2004, 275-280).  An 
analysis of 15 prospective studies with 4-30 years of follow-up in middle-aged to elderly 
adults from several countries showed that the consumption of 3 servings of fish per week, 
a common source of omega3 fatty acid intake, is related to a lower risk of stroke (Larsson 
and Orsini 2011). Further, omega3 fatty acids have also been associated with a decreased 
risk of cognitive impairment in elderly adults and that high fish consumption was 
associated with a slower progression of cognitive decline over 5 years in middle-aged 
adults (van Gelder et al. 2007, 1142-1147; Kalmijn et al. 2004, 275-280).  One study 
reported lower incidence of subclinical infarcts and better white matter grade with greater 
fish intake in older adults (Virtanen et al. 2008, 439-446).  In another cross-sectional 
study conducted among older adults, a dietary intake pattern rich in omega3 fatty acids 
was beneficially related to cognitive function and white matter hyperintensity (Bowman 
et al. 2012, 241-249).  Dietary fatty acid intake in young adults relative to brain MRI 
measures obtained at middle age has not been studied.  
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     Using data from the Coronary Artery Risk Development in Young Adults (CARDIA) 
study, we examined the associations of dietary fat intake over 20 years with structural 
and functional brain MRI measures at a later age.  We hypothesize that average saturated 
fat intake over 20 years will be inversely related to total brain volume, normal gray 
matter volume, normal white matter volume, and white matter FA and positively related 
to ventricular and abnormal white matter volume assessed 25 years post-baseline. 
Further, we expect positive relations of omega3 fatty acid intake with total brain volume, 
gray matter volume, normal white matter volume, and fractional anisotropy and an 
inverse relation with ventricular and abnormal white matter volume.   
 
B.2 Methods 
  
The Institutional Review Board at each institution approved the study protocols and all 
study participants signed informed consent forms.  
 
Study Population 
 
     The CARDIA study is a prospective study of the development and progression of 
CVD risk factors in 5,115 young African American and Caucasian adults aged 18-30 
years at baseline (1985-87) recruited at 4 field centers located in Birmingham, AL, 
Chicago, IL, Minneapolis, MN, and Oakland, CA. Eligibility criteria for a brain MRI 
scan included interest in participation, not claustrophobic, not pregnant, no presence of 
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MRI-contraindication, weighing less than 350 pounds, and under 50 inches for waist and 
hip circumferences. Of the 2018 people approached from the Birmingham, Minneapolis, 
and Oakland field centers, 791 men and women volunteered to have a brain MRI scan at 
year 25. After exclusion criteria were applied, 719 individuals were scanned and 710 and 
701 individuals had valid structural and functional measurements, respectively, after MRI 
exclusions due to technical and participant difficulties.  
     Inclusion criteria for these analyses are valid MRI measurements at year 25 and 
dietary intake assessments for at least two exams among years 0, 7 and 20.  Observations 
were excluded for unusually high (>8000 kcal for men and >6000 kcal for women) or 
low (<800 for men and <600 for women) energy intake at year 0, 7, or 20 (n=4). 
Individuals with missing baseline BMI (n=5) and smoking status (n=6) were excluded.  
The total sample included in the analysis was n=690 for those with volume measurements 
and n=680 for those with fractional anisotropy measurements.  
 
Diet Assessment 
See section A.9, CARDIA Diet History Assessment (page 12)  
 
Magnetic Resonance Imaging 
     At year 25, eligible participants from the three field centers Birmingham, AL, 
Minneapolis, MN, and Oakland, CA underwent an MRI scan by trained personnel after 
pilot testing and approval by the University of Pennsylvania Medical Center.  
Scanning pulse sequences were performed in the order of first to last as follows:  3 plane 
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Gradient echo localizer for positioning, Sagittal 3D T1‐weighted sequence for entire 
brain coverage, Sagittal 3D Fluid Attenuated Inversion Recovery (FLAIR) images from 
matching slice positions in Series 2, Sagittal 3D T2‐weighted images matching slice 
positions in Series 2, Axial Arterial Spin Labeling (ASL) perfusion sequence, Axial ASL 
calibration sequence, and Axial Diffusion Tensor Imaging (DTI) sequence.   
 
     The analysis of MRI images was performed using an automatic algorithm which 
removed extra-cerebral tissue and segmented the brain parenchyma into gray matter, 
white matter, and cerebrospinal fluid. The scanned image was transferred to regions of 
interest (ROIs) from the Jakob Atlas (Shen and Davatzikos 2002, 1421-1439). White 
Matter Lesion Segmentation was used to segment small vessel ischemic disease within 
data sets in order to classify each voxel as either normal or abnormal tissue (Zacharaki et 
al. 2008, 620-627). White matter integrity was evaluated by fitting a tensor to each DTI 
volume and used to calculate fractional anisotropy. 
 
     For this analysis, the brain regions of interest include whole brain, gray matter, white 
matter, and ventricles.  The brain MRI outcomes include total brain volume, normal gray 
and white matter volume, abnormal white matter volume, and total ventricles, which 
were all expressed in cm3; and white matter FA. Total ventricles were defined as the total 
volume of the third and both lateral ventricles.  
 
Statistical Analysis   
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     The SAS software (version 8; SAS Institute, Cary, NC) was used for all analysis.  The 
distributions of brain MRI measures were checked for normality. Dietary intakes at years 
0, 7, and 20 were averaged and included in the models as a continuous variable.  
Descriptive statistics for continuous variables were presented as means (SD) and 
categorical variables presented as frequencies (%).  Because differential results have been 
observed for cognitive decline in men and women (22), effect modification of gender was 
evaluated on the relation between dietary fat intake and brain MRI measures(p for 
interaction <0.05 was found for abnormal white matter, total ventricle volume, normal 
gray matter, normal brain volume, and normal white volume). Thus, Spearman partial 
correlations by gender evaluated the relations between dietary fat intakes and brain MRI 
measures, adjusting for age, race, year 25 education, year 25 smoking, average (year 
0,15, and 20) energy intake, average (year 0,15, and 20) alcohol intake, change in BMI 
between year 0 and 25, y0 BMI, and total intracranial volume. P-values less than or equal 
to 0.05 were deemed as statistically significant. 
 
B.3 Results 
 
     The average age at the time of the MRI scan (year 25) was 50.2 years for males and 
50.4 years for females (Table 1).  Women reported significantly more years of education 
than men; while the proportion of current smokers and alcohol drinkers was similar for 
both men and women. At baseline, men reported greater intake for energy (kcal), alcohol 
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(g/day), and % kcal from total and saturated fat, while women reported greater % kcal 
from carbohydrates (Table 1).  Although BMI was similar between men and women, 
systolic and diastolic blood pressures were greater among men than women.  
 
 Ventricle volume and intracranial volume were significantly greater in men than in 
women (Table 2). Abnormal white volume was significantly greater in women than in 
men, although the volumes were quite small for both sexes and right-skewed.   
 
 Spearman partial correlation coefficients evaluated the relations between the 20-
year average of dietary fat intake and brain MRI measures (Table 3). Total fat intake was 
not related to any of the brain MRI measures in men or women.  Saturated fat (% and 
gm) was correlated with abnormal white matter in women only.  In both men and women, 
there were significant inverse correlations between omega3 fatty acid intake (% and mg) 
and abnormal white matter volume. In men, but not women, saturated fatty acids (% and 
g) were inversely correlated with white matter FA and omega3 fatty acid intake (%) was 
inversely correlated with total ventricle volume.   
 
B.4 Discussion  
 
          We observed in both men and women significant inverse correlations between 
omega3 fatty acids and abnormal white matter volume.  Although, saturated fat was 
positively related to abnormal white matter volume in women, this relation was not 
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significant in men.  Further, we observed in men an inverse correlation between saturated 
fat and white matter FA. Finally, omega3 fatty acids were inversely related to ventricle 
volume in men, but not women.  Though, little research has been conducted in this area, 
our study results support the findings of studies that have examined the relations of 
dietary fat intake with cognitive function (or decline) and stroke. These results support 
the theory that a healthier dietary fat intake including intake of omega3 fatty acids are 
inversely associated with white matter abnormalities in men and women respectively.  
     Omega3 fatty acids play an important role in the development and maintenance of 
brain function (21), supporting our observation that omega3 fatty acid intake over 20 
years was beneficially associated with brain MRI measures in middle-aged adults.  
Omega3 fatty acids are required for development and function of both the brain and the 
retina (Neuringer, Anderson, and Connor 1988, 517-541), are involved in the regulation 
of blood flow within the cerebrum (Bourre 2004), as well as being necessary for synapse 
development and thus affect the density of axonal projections (McGahon et al. 1999, 305-
314).  Supplemental omega3 fatty acids have been associated with a reversal of cerebral 
atrophy in schizophrenia and Huntington’s Disease as well as in the reduction of 
ventricular volume in treatment-resistant depression (Puri et al. 2000, 57; Puri et al. 2002, 
123; Logan 2003, 410-425). Omega3 fatty acid supplementation resulted in 
neuroprotection from ischemic events in neonates and likely occurs through its anti-
inflammatory action (Zhang et al. 2010, 2341-2347). Similarly an increased intake of 
omega3 fatty acid-containing fish has been associated with a decreased risk for ischemic 
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stroke in men and women (Larsson and Orsini 2011; Larsson, Virtamo, and Wolk 2011, 
487-493). 
     Omega3 fatty acids affect brain function through several mechanisms involving 
effects on neuron signaling and physical processes such as membrane fluidity and bilayer 
thickness (Horrocks and Farooqui 2004, 361-372). The importance of these mechanisms 
is supported by evidence that deficiencies of docosahexanoic acid are associated with 
decreased neuron signaling, gene expression, and inflammation (Horrocks and Farooqui 
2004, 361-372). Thus it is reasonable that omega3 fatty acid intakes may result in 
decreased inflammation and improved brain function and integrity through, for example, 
the expression of appropriate genes required for neuronal survival and growth (Horrocks 
and Farooqui 2004, 361-372). 
      As we expected, saturated fat intake was inversely associated with white matter 
integrity in men. Saturated fat intake has had a pronounced negative impact on the 
function of the brain in addition to its well-known role in the promotion of heart disease. 
Saturated fat has been related to increased risk for dementia (Del Parigi et al. 2006, 1-19). 
Additionally, a diet high in saturated fat has been associated with increased risk of 
cognitive decline over 6 years in a biracial community population (Morris et al. 2004, 
1573-1579).  
     The effect of dietary saturated fat intake on brain MRI measures may occur through 
several potential mechanisms. One mechanism involves changes in the composition of 
phospholipids in the plasma membrane. Dietary intake of saturated fat is associated with 
alteration in phosphatidylcholine profile in neuronal membranes indicating that 
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membrane permeability and integrity may be affected (Greenwood and Winocur 1996, 
451). Another potential mechanism to account for the effect of saturated fat intake on 
brain function involves the upregulation of inflammatory processes. High fat diets are 
shown to increase the formation of reactive oxygen species and NADPH-mediated 
oxidative stress (Zhang et al. 2005, 318-325). Further, high-fat diets also increase 
inflammatory prostaglandin 2, COS-2, and NKFB translocation in the cerebral cortex of 
rats (Zhang et al. 2005, 318-325). Physiological processes that affect cortical dynamics 
via astrocytes in mammals may involve metabolic responses to dietary challenges such as 
dietary saturated fatty acids (Cunningham et al. 2006, 5597-5601). Direct effects of these 
stressors on inflammatory processes could result in calcium influx and subsequent 
activation of glial cells resulting in deterioration of brain processes. Blood flow acts 
directly on astrocytes in the brain and vasoactive compounds present in the blood have 
marked changes on astrocyte and subsequent brain activity (Rossi 2006, 159-161). 
     The differences in the relations involving saturated fat and omega3 fatty acid intake 
between men and women could be explained by the structural and connective gender 
disparities in the brain. Studies show that there are structural differences as well as 
differences in cerebral blood flow between men and women which may affect the 
mechanistic pathway for the effects of diet on the brain (Schlaepfer et al. 1995, 129-135). 
Similarly differences exist in the connectivity between brain hemispheres and the effects 
of brain connectivity on cognition between men and women (Davatzikos and Resnick 
1998, 635-640). This may account for our findings in men, but not in women, of an 
inverse correlation between saturated fat and white matter FA. Additionally the presence 
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of the estrogenic effect on omega3 fatty acid storage in women may account for the 
differences in the effects on this nutrient on the brain (Giltay et al. 2004, 1167-1174). It 
was of particular importance that we examined the correlations separately for men and 
women to clarify these gender specific effects. The absence of any significant 
associations between gray matter and the MRI measures could be due to inadequate 
sample size. Additionally, the effect of diet on the volume of the gray matter may involve 
nutrient-nutrient or gene-nutrient interactions.   
Strengths and limitations 
One limitation of our study was the use of self-reported dietary intake. However, the 
CARDIA diet history questionnaire was validated (McDonald et al. 1991, 1104). Further, 
averaging dietary intake across years 0, 7, and 20 increased the precision within reported 
individual dietary intake.  Additionally, assessment of diet using the CARDIA diet 
history captured brand names of fat products used in food preparation and added at the 
table which increased the validity of fatty acid intake. Knowing the type of fatty acids in 
the food product facilitates correct classification of type of fat intake, and therefore, 
reduces the measurement error of dietary fat intake.  A common limitation with 
traditional brain MRI analysis is measurement error. However, in this study high 
resolution, 3T, 3D isotropic imaging was performed and statistically sophisticated voxel-
based analysis was used which improved the accuracy and precision in measurement and 
quality control samples were performed. Another limitation is that MRI measures were 
not taken at any time points prior to year 25. Thus, conclusions about the earlier relations 
between dietary fat and brain MRI remain unknown. A major strength was the 
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prospective study design of our study examining usual dietary fat intake over 20 years 
relative to brain MRI measures at year 25 in a biracial population of adult men and 
women.  
 
B.5 Conclusion 
 
     Our study sheds light on important associations between earlier dietary fat intake and 
the subsequent brain MRI measures that are indicative of overall brain health. In addition, 
our findings support the general recommendation to limit intake of saturated fat for 
maintaining brain health in addition to the widely discussed cardiovascular health 
benefits. Future studies are warranted to examine these relations in larger populations and 
over a longer period of time.   
 
 
C. The Relation between Blood Lipid Levels and Brain MRI Measures 
 
C.1 Introduction 
 
     MRI measures such as brain volume and fractional anisotropy, a marker of axonal 
organization and directional congruency, are subclinical markers of cognitive function 
and stroke risk (Tiberio et al. 2005, 1001-1007; Longstreth et al. 1996, 1274-1282) Little 
research has been done to determine the associations between blood cholesterol and 
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triglycerides with MRI measures of brain function and stroke markers. In particular we 
are interested in the association between blood low-density lipoprotein (LDL), high-
density lipoprotein (HDL), and triglyceride levels and MRI measures in the brain taken 
25 years later.  
     A cross-sectional study in 44 ischemic patients showed that blood levels of oxidized 
LDL-cholesterol are associated with ischemic lesion detected by diffusion weighted MRI 
imaging and predicts the size of brain infarction (Uno et al. 2005, 94-102). A cross-
sectional study in 139 centarians showed that blood HDL-cholesterol is positively 
associated with cognitive performance and is expected to be positively associated with 
measures of cognitive performance (Atzmon et al. 2002, M712). In a study of 89 non-
demented old people high levels of total and LDL-cholesterol were associated with a low 
gray matter volume (Whalley et al. 2003, 173-176). In a population of 18 multiple 
sclerosis patients assessed over a 6 month period, blood total and LDL-cholesterol was 
associated with an increasing number of lesions in the brain (Giubilei et al. 2002, 109-
112).  
With regard to cognitive function, cross-sectional and prospective studies involving 4316 
Medicare recipients over 65 years of age from Manhattan, NY showed that elevated 
blood LDL and decreased blood HDL-cholesterol are risk factors for vascular dementia 
(Reitz et al. 2004, 705). High total cholesterol levels are associated with memory 
dysfunction and cognitive decline in a longitudinal study with 249 community volunteers 
around 70 years of age (Desmond et al. 1993, 162). A 4 year follow-up longitudinal study 
with 1037 postmenopausal women with cardiovascular heart disease found that LDL 
   31 
 
cholesterol with associated with cognitive impairment as assessed with a mini mental 
state examination (Yaffe et al. 2002, 378).  
     Few studies have examined the influence of blood lipids on subclinical MRI measures 
of the brain, especially in younger adults.  Therefore, we examined the associations of 
early exposure to blood lipid levels (age 18-30 years at baseline) with structural and 
functional brain MRI measures at a later age (43-55 years).  We examined the relation of 
blood lipids with normal/abnormal brain volume and fractional anisotropy. We predict 
that blood LDL-cholesterol and triglyceride levels will be positively associated with 
reduced brain volume and axonal organization assessed with fractional anisoptropy 
measurements. We also predict that HDL-cholesterol will be associated with greater brain 
volume and axonal organization.  
 
C.2 Methods 
 
     All participants of our study signed informed consent forms prior to the study and the 
Institutional Review Board at each of the three involved institution approved of the study 
protocols.  
 
Study Population 
 See Section A.9, page 11 for description of the population 
 
     Inclusion criteria for these analyses are valid MRI measurements at year 25 and valid 
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blood lipid measurements. Additionally a minority of individuals scanned in the Chicago 
center were excluded (n=5). After this exclusion the total study sample was 710. 
Following missing MRI data exclusions and missing confounding variable data (n=20), 
the total sample was 690 for volume measurements and 680 for fractional anisotropy 
measurements.   
 
Clinical Assessment of Blood Lipid Parameters 
 
     Subjects fasted for >8 hrs and were asked to avoid smoking and physical activity for 
two hours prior to the CARDIA exam for the analysis of blood lipid parameters. The 
blood samples were stored at -70 degrees Celcius. The clinical parameter of importance 
for our proposed study is the plasma levels of total cholesterol and triglycerides, risk 
factors for coronary heart disease (Wilson et al. 1998, 1837-1847); however, LDL-c and 
HDL-c were also examined. 
 
Magnetic Resonance Imaging 
See section A.9 (page 13-14) for description of MRI 
      
Statistical Analysis  
 
     The SAS software (version 8; SAS Institute, Cary, NC) was used for all analysis. The 
distribution for abnormal matter was skewed, however we employed spearman 
   33 
 
correlations in our analysis to normalize the distribution. Because studies of cognitive 
decline showed differences by gender group, data were stratified (Gur et al. 1991, 2845).  
Blood lipid levels at years 0, 2, 5, 7, 10, 15, 20, and 25 were averaged and included in the 
models as a continuous variable.  
 
     Descriptive statistics for continuous variables were presented as means (SD) or (SE)..  
Spearman correlation analysis was used to evaluate the relations between blood lipid 
levels over 25 years and brain MRI measures at year 25 stratified by gender, adjusting for 
age, race, year 25 education, year 25 smoking, % kcal from saturated fat (average of 
years 0, 7, and 20), change in BMI between year 0 and 25, baseline BMI, alcohol intake 
(average of years 0, 7, and 20) and intracerebral volume. P-values less than or equal to 
0.05 were deemed as significant. 
 
C.3 Results 
  
     As previously described in Table 2, ventricle volume and intracranial volume were 
significantly greater in men than in women. Abnormal white volume was significantly 
greater in women than in men. White matter FA was greater in women than men.  Total 
cholesterol was similar between men and women; however, triglycerides and LDL-
cholesterol were higher in men than women, while HDL-cholesterol levels were higher in 
women (Table 4).  
     Table 5 shows the Spearman partial correlation coefficients for the relations between 
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the 25-year average blood lipids and the MRI measures. In men there were significant 
inverse relations between total cholesterol and total brain volume. In men there were 
significant positive correlations for both total cholesterol and LDL-cholesterol with total 
ventricle volume. In women there was a significant inverse correlations for total 
cholesterol and triglycerides with total brain volume and an inverse correlation between 
triglycerides and normal gray matter.   
 
C.4 Discussion 
 
     Our study findings support our hypothesis that total cholesterol is inversely associated 
with total brain volume in men and women and that triglycerides are inversely associated 
with total brain and normal gray volumes in women. In men total and LDL cholesterol 
was positively associated with total ventricle volume. It is possible the beneficial effects 
of HDL cholesterol on brain function reported in prior studies that examined older 
populations suggesting the relationship may be strengthened with increasing age (Atzmon 
et al. 2002, M712; Reitz et al. 2004, 705).  
     Blood lipids may influence the MRI parameters through effects on inflammation, 
brain function, and neuronal integrity.  For example, synaptogensis and the effect of 
cholesterol homeostasis on the neuronal proteome and neuron degeneration may be 
affected (Goritz, Mauch, and Pfrieger 2005, 190-201; Tsaousidou et al. 2008, 510-515; 
Wang et al. 2008, 1606-1614). It is possible that decreases in brain volume and axonal 
density may be present within the brain as a result of elevated cholesterol.  
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     The correlation between blood lipid levels and brain MRI measures may be accounted 
for through several potential mechanisms. One mechanism involves an inflammation-
mediated damage of the blood brain barrier. Blood lipids have an established and marked 
role on the upregulation of local inflammation (Abela 2010, 156-164). For example, a 
study in rabbits showed that dietary cholesterol doubled the levels of beta-amyloid in the 
hippocampal cortex which may be related to the observed appearance of beta-amyloid 
immunoreactivity in the neuropil. The authors concluded that cholesterol-mediated 
vascular inflammation can lead to the breaking of the blood-brain barrier integrity and 
produce biochemical alterations that result in the formation of the beta-amyloid protein 
(Sparks et al. 2000, 335-344). It is expected that the disruption in the blood brain barrier 
may cause other alterations in the brain and subsequent inflammation. Additionally direct 
effects of these stressors on inflammatory processes could result in calcium influx and 
subsequent activation of glial cells resulting in deterioration of brain processes. Changes 
in blood flow that occur as a result of blood lipid levels could affect the activity of 
astrocytes. Blood flow acts directly on astrocytes in the brain and affects subsequent 
brain activity (Rossi 2006, 159-161; Rossi 2006, 159-161). Activation of astroglial cells 
by physiological processes results in subsequent fluctuations in brain tissue oxygenation 
and potentially cognitive function. Specifically, cross-talk between neurons and glial cells 
resulting in an influx of calcium into glial cells accounts for fluctuations in BOLD signal 
detected by fMRI (Rossi 2006, 159-161). The differences in the relationships involving 
saturated blood lipids between men and women could be explained by the structural and 
connective gender disparities in the brain. Studies show that there are structural and 
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vascular differences between men and women which may affect the mechanistic pathway 
for the effects of blood lipids on the brain (Schlaepfer et al. 1995, 129-135). Similarly 
differences exist in the connectivity between brain hemispheres and the effects of brain 
connectivity on cognition between men and women (Davatzikos and Resnick 1998, 635-
640).  
     To elucidate the biological impact of the previously observed significant relationships 
further research is required. Specifically, the impact of the potential effects of 
cardiovascular disease risk factors on MRI measures upon the biological processes 
involved in the development and progression of cognitive malfunction and stroke 
requires studies examining protein expression within cells, and other biological assays 
within the brain, for example.  
Strengths and limitations 
     A common limitation with traditional brain MRI analysis is measurement error. 
However, this study utilized a sophisticated voxel-based analysis was used which 
improved the accuracy and precision in measurement. A major strength was the 
prospective study design of our study examining blood lipid levels over 25 years relative 
to brain MRI measures at year 25 in a biracial population of adults. The measurement of 
brain MRI parameters at a time subsequent to when blood lipids were measured allows 
for a prospective analysis of the observed correlations. In contrast to other studies, blood 
lipids in our population were assessed for over 25 years beginning in young adulthood. 
 
C.5 Conclusion 
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     Our results suggest that early exposure to blood lipids affect the status of the brain as 
assessed by MRI measures taken at a later age. Thus, the idea that the blood lipid levels 
in younger populations are important for the maintenance of proper cognitive function 
and the prevention of cerebrovascular and neurodegenerative diseases is supported. The 
previously observed benefits of HDL-cholesterol on the brain may be manifested later on 
in the life-span than the middle-age of the individuals used for the brain MRI scans in our 
study. It is also possible that a larger sample size is necessary to see the effect. Future 
studies may look at these relationships in larger populations and over a longer period of 
time. For example, it would be important to see how blood lipid levels in younger or 
older populations affect the status of the brain of the same population at an elderly age. It 
is likely that levels of blood lipids in the healthy range are important at all stages of the 
life cycle for brain health.   
 
 
 
D. Future Directions 
     In light of the relationships observed in these studies between dietary fat intake and 
blood lipids with subsequent brain MRI measures, there are several future directions 
which would be appropriate to support the theories and mechanisms which are 
responsible for a potential causative effect. A combination of cell, animal, and human 
studies, both short and long-term, would elucidate the mechanisms and direction of 
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effect. The following are ideal future studies: 
• Brain cell culture studies examining the effect of blood lipids on intracellular 
processes 
• Animal studies which examine long term effects of dietary fat (both omega and 
saturated) on brain MRI measures 
• Animal studies which examine short term effect of dietary fat overload on 
inflammatory markers and brain MRI measures 
• Human prospective studies similar to those done here with a larger n size 
• Human intervention studies examining short term effects of dietary fat on brain 
MRI measures 
• Human intervention/cohort studies examining long-term effects of dietary fat on 
brain MRI measures 
• Human clinical studies examining treatment of cognitive decline and/or stroke 
propensity with omega-3 dietary fat  
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Appendix 1: Tables  
 
Table 1. Mean (SE) or frequency (%) of year 25 demographic and clinical 
characteristics and average dietary intake (years 0, 7, 20) among African American 
and Caucasian men and women, CARDIA (n=690) 
*Adjusted for age and race 
 
 
 
 
 
 
Characteristics Men (n=326) Women (n=364) p-value 
Age, years 50.2 (0.19) 50.4 (0.18) 0.54 
Race, % African American 38.2 (2.65) 42.5 (2.51) 0.24 
Education, years 14.7 (0.14) 15.1 (0.13) 0.01 
Current smoker, % 17.1 (2.05) 15.7 (1.94) 0.61 
Current drinker, % 18.5 (2.25) 23.5 (2.12) 0.19 
Daily Dietary Intake    
Energy, kcal 3321 (57) 2174 (53) <0.001 
Total fat, %kcal 36.8 (0.28) 35.8 (0.27) 0.007 
PUFA, %kcal 7.3 (0.10) 7.3 (0.10) 0.99 
Saturated fat, %kcal 12.9 (0.14) 12.5 (0.13) 0.03 
Omega3, %kcal 0.046 (0.003) 0.051 (0.003) 0.29 
Carbohydrate, %kcal 46.6 (0.36) 49.0 (0.34) <0.001 
Protein, %kcal 14.7 (0.12) 14.8 (0.12) 0.62 
Alcohol , g 16.3 (0.87) 7.4 (0.82) <0.001 
Clinical characteristics    
Baseline Body mass index , (kg/m2) 23.8 (0.24) 23.9 (0.22) 0.56 
Yr 25 Systolic blood pressure, mmHG 121 (0.78) 116 (0.74) <0.001 
Yr 25 Diastolic blood pressure, mmHG 75(0.57) 72 (0.54) 0.008 
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Table 2. Average year 25 brain MRI measures* among African American and 
Caucasian men and women, CARDIA (n=690) 
 
Brain MRI Measures* Males (n=326) Females (n=364) p-value 
Total Brain Volume (cm3) 978.90 (1.79) 984.08 (1.67) 0.06 
Normal Gray Matter (cm3) 514.84 (1.35) 518.49 (1.27) 0.08 
Normal White Matter (cm3) 464.06 (1.50) 465.59 (1.41) 0.50 
Abnormal White Volume (cm3) ** 0.20  0.30 <0.001 
Total Ventricle Volume (cm3)  22.84 (0.60) 20.78 (0.56) 0.02 
White Matter Fractional Anisotropy† 0.304 (0.001) 0.308 (0.001)         
0.08 
Intracranial Volume‡ 1287 (5.60) 1138 (5.30) <0.001 
*Adjusted for age, race, and intracranial volume (ICV), except ICV; 
**Abnormal white volume is reported as median and assessed with a Wilcoxon median 
test 
†For white matter fractional anisotropy, n=324 for men and n=356 for women. 
‡ICV was adjusted for age and race. 
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Table 3. Spearman correlation coefficients* between average (years 0, 7, 20) dietary 
intake and year 25 brain MRI measures among African American and Caucasian 
men and women, CARDIA (n=690) 
 
Men (n=326)    
 
Dietary fat 
intake 
Normal 
total 
brain 
(cm3) 
Normal 
gray 
matter 
(cm3) 
Normal 
white 
matter 
(cm3) 
Abnormal 
white 
matter 
(cm3) 
Total 
ventricle 
volume 
(cm3) 
White 
matter 
fractional 
anisotropy** 
Total Fat (%) 0.05 
P=0.39 
-0.03 
P=0.60 
0.07 
P=0.21 
0.08 
P=0.17 
-0.07 
P=0.24 
-0.04 
P=0.44 
Total Fat (g) 0.04 
P=0.49 
0.01 
P=0.89 
0.03 
P=0.66 
0.09 
0.12 
-0.07 
P=0.24 
-0.04 
P=0.53 
Saturated Fat 
(%) 
0.02 
P=0.79 
-0.01 
P =0.91 
0.02 
P=0.72 
0.07 
P=0.19 
-0.07 
P=0.22 
-0.14 
P=0.01 
Saturated Fat 
(g) 
<-0.01 
P=0.97 
-0.01 
P=0.89 
<-0.01 
P=0.98 
0.05 
P=0.37 
-0.07 
P=0.19 
-0.12 
P=0.03 
Omega3 Fat 
(%) 
-0.03 
P=0.60 
-0.06 
P=0.29 
0.05 
P=0.41 
-0.11 
P=0.05 
-0.11 
P=0.05 
0.09 
P=0.13 
Omega3 Fat 
(mg) 
=-.02 
P=0.68 
-0.05 
P=0.36 
0.05 
P=0.42 
-0.14 
P=0.01 
-0.10 
P=0.08 
0.10 
P=0.09 
Women (n=364)      
Total Fat (%) 0.05 
P=0.38 
0.01 
P=0.79 
0.04 
P=0.51 
0.09 
P=0.08 
0.02 
P=0.72 
0.05 
P=0.36 
Total Fat (g) 0.03 
P=0.64 
0.01 
P=0.83 
0.01 
P=0.81 
0.06 
P=0.24 
0.03 
P=0.61 
0.04 
P=0.43 
Saturated Fat 
(%) 
-0.01 
P=0.82 
-0.004 
P=0.93 
0.01 
P=0.91 
0.13 
P=0.02 
0.07 
P=0.19 
-0.05 
P=0.38 
Saturated Fat 
(g) 
-0.01 
P=0.83 
-0.002 
P=0.97 
<-0.01 
P>0.99 
0.13 
P=0.01 
0.08 
P=0.15 
-0.07 
P=0.18 
Omega3 Fat 
(%) 
-0.02 
P=0.71 
0.02 
P=0.67 
-0.03 
P=0.61 
-0.14 
P=0.01 
-0.01 
P=0.80 
0.07 
P=0.20 
Omega3 Fat 
(mg) 
-0.02 
P=0.78 
0.02 
P=0.65 
-0.02. 
p=0.70 
-0.14 
P=0.01 
-0.02 
P=0.79 
0.06 
P=0.24 
*Adjusted for age, race, education, y25 smoking, y0 BMI, change in BMI between y0 
and y25, energy and alcohol intake, and intracranial volume (volume measures only).   
**For white matter fractional anisotropy, n=324 for men and n=356 for women. 
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Table 4. Mean* (SE) fasting plasma lipids over 25 years among African American 
and Caucasian men and women, CARDIA (n=690) 
 
Characteristics Males  (n =326) Females (n =364) p-value 
Total Cholesterol, mg/dL 184.28 (1.59) 181.94 (1.50) 0.28 
Triglycerides, mg/dL 107.95 (3.30) 79.95 (3.12) <0.001 
LDL Cholesterol, mg/dL 113.87 (1.48) 108.01 (1.40) 0.004 
HDL Cholesterol, mg/dL 49.37 (0.68) 57.81 (0.64) 0.008 
*Adjusted for age and race  
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Table 5. Spearman correlation coefficients* between average fasting plasma lipids 
over 25 years and year 25 brain MRI measures among African American and 
Caucasian men and women, CARDIA (n=690) 
Men 
(N=326) 
     
Fasting 
plasma 
lipids 
Total 
Brain 
Volume 
(cm3) 
Normal 
gray 
matter 
(cm3) 
Normal 
white 
matter 
(cm3) 
Abnorm
al White 
Matter 
(cm3) 
Total 
Ventricle 
(cm3) 
White** 
Matter 
Fractional 
Anisotropy 
Total 
Cholesterol, 
mg/dL 
-0.12 
P=0.03 
-0.05 
P=0.38 
-0.10 
P=0.07 
-0.07 
P=0.24 
0.11 
P=0.05 
-0.005 
P=0.93 
Triglyceride
s (mg/dL) 
-0.04 
P=0.48 
0.04 
P=0.44 
-0.10 
P=0.08 
-0.003 
P=0.96 
0.04 
P=0.44 
0.02 
P=0.71 
LDL 
Cholesterol 
(mg/dL) 
-0.07 
P=0.20 
-0.02 
P=0.76 
-0.07 
P=0.20 
-0.07 
P=0.23 
0.12 
P=0.04 
0.01 
P=0.80 
HDL 
Cholesterol 
(mg/dL) 
-0.04 
P=0.53 
-0.09 
P=0.11 
0.04 
P=0.49 
-0.02 
P=0.71 
-0.01 
P=0.77 
-0.03 
P=0.55 
Women (N=364)      
 Total 
Brain 
Volume 
(cm3) 
Normal 
gray 
matter 
(cm3) 
Normal 
white 
matter 
(cm3) 
Abnorm
al White 
Matter 
(cm3) 
Total 
Ventricle 
(cm3) 
White** 
Matter 
Fractional 
Anisotropy 
Total 
Cholesterol, 
mg/dL 
-0.11 
P=0.04 
-0.06 
P=0.23 
-0.06 
P=0.29 
0.005 
P=0.93 
0.06 
P=0.28 
-0.03 
P=0.60 
Triglyceride
s (mg/dL) 
-0.12 
P=0.03 
-0.15 
P<0.01 
-0.03 
P=0.55 
-0.04 
P=0.47 
0.08 
P=0.12 
-0.08 
P=0.16 
LDL 
Cholesterol 
(mg/dL) 
-0.09 
P=0.11 
-0.03 
P=0.53 
-0.05 
P=0.40 
-0.01 
P=0.82 
0.05 
P=0.33 
-0.03 
P=0.57 
HDL 
Cholesterol 
(mg/dL) 
-0.02 
P=0.75 
-0.01 
P=0.79 
0.02 
P=0.76 
0.03 
P=0.60 
-0.06 
P=0.30 
0.06 
P=0.30 
*Adjusted for age, race, education, year 25 smoking, change in BMI between years 0 and 
5, year 0 BMI, average saturated fat%, and alcohol intake, and intracranial volume  
**For fractional anisotropy measurements, n=324 for men and n=356 for women 
